Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Relief Therapeutics Collaboration Agreement (Details)

v3.22.1
Commitments and Contingencies - Relief Therapeutics Collaboration Agreement (Details) - Relief Therapeutics Collaboration Agreement [Member] - USD ($)
$ in Millions
Jan. 10, 2022
Mar. 31, 2022
Related Party Transaction [Line Items]    
Reimbursements for expenses   $ 10.9
Pending Litigation    
Related Party Transaction [Line Items]    
Litigation damages sought by Company $ 185.0